CREAL, the Swiss innovator in light field display technology, today announced the final close of an $8.9 million equity funding round. The round was led by ZEISS, with participation from new and existing investors, including members of the UBS private investor network.
This latest investment underscores the increasing momentum behind light field technology and its potential to significantly enhance augmented reality (AR) and vision care. The funds will accelerate CREAL’s mission to deliver natural, comfortable, and healthy digital visual experiences by advancing its proprietary light field display technology.
The new capital will primarily fuel two key areas:
1.) Delivery of a digitized vision care platform – This platform, based on CREAL’s light field display technology, will be supplied to users under a licensing agreement to power ZEISS’ next-generation diagnostic and treatment devices.
2.) Continued miniaturization of CREAL’s AR light field module – This development aims to enable seamless integration into lightweight, fashionable AR glasses, targeting both enterprise and, eventually, consumer markets.
With this new funding round, CREAL has now raised over $32 million to date. The company is backed by leading investors, including Swisscom Ventures, Verve Ventures, DAA Capital Partners, and now ZEISS, further solidifying its position at the forefront of AR display innovation.
KEY QUOTE:
“As AI reshapes how we work and create, AR is poised to become the killer interface to this new era. But if we’re going to wear AR glasses all day, they must imperatively be healthy, comfortable, and natural to use. That’s why we’re focused on delivering AR glasses that uniquely project digital imagery with real-world depth — fully supporting the natural focusing mechanism of the human eye. This is one of the key foundations for immersive spatial computing.”
Tomas Sluka, CEO and Co-Founder of CREAL
